Skip to content

Effect of Pulsed Electromagnetic Field Stimulation on Localized Pediatric Osteomyelitis

Effect of Pulsed Electromagnetic Field Stimulation on Localized Pediatric Osteomyelitis : Randomized Control Trail Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06084754
Acronym
PEMF
Enrollment
20
Registered
2023-10-16
Start date
2023-11-27
Completion date
2024-02-29
Last updated
2023-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteomyelitis

Keywords

Osteomyelitis, Pulsed Electromagnetic Field

Brief summary

This study will be applied to evaluate effect of pulsed electromagnetic field on pediatric localized osteomyelitis.

Detailed description

Twenty (11 girls, 9 boys) patients will participate in this study. Their ages ranged from 5 to 16 years. They will randomly divide into two groups. Group A ( study group) will receive pulsed electromagnetic field in addition to medical treatment three times per week for two months , Group B(control group ) will receive medical treatment only.

Interventions

pulsed electromagnetic field will be over the site of osteomyelitis where patient in supine lying position. the treatment parameters will be set as10 HZ frequency , 20 gauss amplitude, duration about 120 minutes.

DRUGAntibiotics

Vancomycin IV injection 1gm divided 250mg every 6hours

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

double blinded

Eligibility

Sex/Gender
ALL
Age
5 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

1. All patients suffering from localized osteomyelitis in one or both lower limbs 2. All patients will be assessed by a physician before starting the study procedures.

Exclusion criteria

1. Patients with immune disorders . 2. Patients who suffer from any systemic diseases that may interfere with the objectives of the study.

Design outcomes

Primary

MeasureTime frameDescription
Changing of osteomyelitis signspre treatment and post two months of treatmentthrough CT scan

Countries

Egypt

Contacts

Primary ContactNorhan M. Eltayeb, MSc candidate
1400534@st.pt.cu.edu.eg01288053957
Backup ContactNessrien A. AbdelRashid, Ass. professor
nessrien.afify@pt.cu.edu.eg01143872680

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026